• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad June 15 Dr Reddy's Laboratories Ltd, the Hyderabad-based pharma major, has expanded its presence in Africa with the opening of its 40th overseas office in Lagos, Nigeria, in partnership with Phillips Pharmaceuticals.

This distributor-based model will serve the $280-million Nigerian pharmaceutical market. The company is initially targeting therapeutic areas such as gastroenterology, diabetes and cancer.

According to a company press release, the first phase of launch will see major brands such as Omez, Reclide, Diavista, Osetron and Docetere 20 mg (from amongst the range of oncology drugs) being introduced in the Nigerian market.

Commenting on the development, Mr Rajesh Kumar, Head — AMEEERA (Asean, Middle East, Eastern Europe, Rest of Africa) region said, "We are committed to bringing quality and affordable medicine to people across the world and the initiation of our Nigerian operations is one more step in that direction."

Dr Reddy's already has presence in South Africa, Ghana, Sudan, Kenya, Uganda, Tanzania, Rwanda and the Democratic Republic of Congo, the release added.

More Stories on : Overseas Investments | Pharmaceuticals | Dr. Reddy's Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Aurobindo gets USFDA nod

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line